AACR: Jennifer Wargo, M.D., elected Fellow of the AACR Academy Jennifer Wargo, M.D., professor of Surgical Oncology and Genomic Medicine at The University of Texas MD Anderson Cancer Center, has been elected to the 2026 class of Fellows of the American Association for Cancer Research (AACR) Academy in recognition of her pioneering work to define interactions between the microbiome, cancer biology and treatment response.

Our Jennifer Wargo, M.D., has been elected to the 2026 @theaacr.bsky.social class of fellows in recognition of her pioneering work to define interactions between the microbiome, cancer biology and treatment response.

More about this prestigious honor: spr.ly/6012B6NHmG #AACR26 #OncSky #EndCancer

Sections Learn about the sections that make up the Neurosurgery department at MD Anderson, a top-ranked cancer center.

At @mdanderson.bsky.social, we resect the unresectable. Learn more about how our team removed a complex chordoma ⬇️ @cflabsresearch.bsky.social #oncsurgery #endcancer

www.mdanderson.org/research/dep...

AACR: Immunotherapy pioneer James P. Allison, Ph.D., honored with Award for Lifetime Achievement in Cancer Research James P. Allison, Ph.D., Regental professor and chair of Immunology, vice president of immunobiology and founding director of the James P. Allison Institute™ at The University of Texas MD Anderson Can...

Nobel laureate James Allison, Ph.D., will be honored with the Award for Lifetime Achievement in Cancer Research at this year's @theaacr.bsky.social Annual Meeting.

More about this recognition of Dr. Allison's lifelong commitment to scientific discovery: spr.ly/6019B6230d #EndCancer

What is a menin inhibitor? What are menin inhibitors? Leukemia expert Elias Jabbour, M.D., discusses which patients make the best candidates for this novel cancer therapy, how they work and possible side effects.

Menin inhibitors are a new form of cancer treatment for certain types of leukemia.

But you may be wondering how they work and for which leukemia types? Our Dr. Elias Jabbour explains: spr.ly/63321B62yaJ #OncSky #EndCancer

Immunosuppressants: What is their role in cancer care? What are immunosuppressants? Jeremy Ramdial, M.D., explains how these drugs work, their role in stem cell transplants, and how they help manage graft vs. host disease.

Sometimes, cancer patients are given immunosuppressants as part of their treatment plan.

Our Dr. Jeremy Ramdial explains what they are, why someone may need them and how they work: spr.ly/63324B6LTa8 #OncSky #EndCancer

Okra water: Should you be drinking it? Is okra water actually good for you? Senior clinical dietician Rachel Murphy weighs in on the science behind the trend, from its alleged blood sugar and weight loss benefits to the potential risks.

Proponents of drinking okra water claim it can help with a variety of systems in your body. But do any of those claims hold up?

Clinical Dietitian Rachel Murphy shares what you should know: spr.ly/63320B6I8RG #OncSky #EndCancer

Researchers find new target to sensitize pancreatic tumors to immunotherapy Researchers find new target to sensitize pancreatic tumors to immunotherapy

What if there was a way to identify which patients with pancreatic cancer were more likely to benefit from immunotherapy?

A group of UT MD Anderson researchers found a biomarker that may be able to do that. Learn more: spr.ly/6012B6x8Lj #OncSky #EndCancer

Metastatic melanoma survivor trusts UT MD Anderson’s expertise and research Joe Eastin faced multiple melanoma recurrences before seeking a second opinion at UT MD Anderson. Here he shares how immunotherapy and a caring team of doctors and researchers helped him through a metastatic melanoma diagnosis.

“I think the science around advanced melanoma treatment is pretty amazing," says Joe Eastin after receiving immunotherapy for metastatic melanoma at UT MD Anderson.

Why he's excited about the future of immunotherapy research: spr.ly/63327B6aDhv #OncSky #EndCancer

Researchers identify blood-based biomarker for cancer risk in people with Lynch Syndrome Researchers identify blood-based biomarker for cancer risk in people with Lynch Syndrome

Researchers at UT MD Anderson have identified a blood-based biomarker that could help detect cancer risk earlier in people with Lynch syndrome.

Read more: spr.ly/6017B6QjF7 #OncSky #EndCancer

Blood in semen (hematospermia): Is it a sign of cancer? Blood in semen, also known as hematospermia, usually is not a sign of cancer or anything serious. But it’s also not normal. Urologic oncologist Lisly Chéry, M.D., shares when to see a doctor for blood in your semen and how it’s treated.

There are some infections or inflammatory conditions that can cause you to see blood in your semen, which can be a concerning thing to see.

But Dr. Lisly Chéry shares why it usually isn't something serious: spr.ly/63321B6tmH9 #OncSky #EndCancer

3 reasons appendix cancer is hard to diagnose  Appendix cancer is now known to be distinct from colorectal cancer. But it can still be difficult to diagnose. Why? Gastrointestinal oncologists John Paul Shen, M.D. and Beth Melmink, M.D., weigh in.

Drs. John Paul Shen and Beth Helmink recently shared why appendix cancer can be difficult to diagnose.

Read their insights here: spr.ly/63320B6UtIC #OncSky #Endcancer

www.facebook.com/share/18S48d.... Please donate if you can. #endcancer

Stage IV cervical cancer survivor thankful for immunotherapy clinical trial Paulette Burkhart was 70 when she was diagnosed with stage IV cervical cancer. Here she shares why she’s glad she enrolled in an immunotherapy clinical trial at UT MD Anderson and encourages others facing cancer to ask about clinical trials as well.

When Paulette Burkhart was diagnosed with advanced cervical cancer, she met with Dr. Roni Wilke, who told her about an immunotherapy clinical trial.

Two years later, the cancer has had a complete response, and Paulette is doing well: spr.ly/63324B6oFt6 #OncSky #EndCancer

Radiation therapy improves outcomes for 'supermassive' bile duct tumors A new study from researchers at The University of Texas MD Anderson Cancer Center demonstrates that a specialized high-dose type of radiation delivery may significantly improve outcomes for patients with large bile duct tumors in the liver, known as intrahepatic cholangiocarcinoma.

A new study found that a specialized high-dose type of radiation delivery may significantly improve outcomes for patients with intrahepatic cholangiocarcinoma, when given with standard-of-care chemotherapy.

Learn more: spr.ly/6019B6ovs5 #OncSky #EndCancer

Researchers from UT MD Anderson developed a first-in-class antibody that targets a protein over expressed in many cancer types, allowing for the creation of a new treatment that brings targeted radiation directly to tumor cells.

Learn more: spr.ly/6013B6o6uJ #OncSky #EndCancer

Lung cancer survivor finds care, support and connection at UT MD Anderson After Daniel West was diagnosed with lung cancer, he chose UT MD Anderson for his treatment.

“We liked that at UT MD Anderson, we were able to talk to all my doctors in the beginning," recalls Daniel West. "Lung cancer is such a serious diagnosis, so I liked that they had a plan for my treatment.”

Read his story: spr.ly/63320B6Wt4k #OncSky #EndCancer

Gleason score decoded: What it means, and how it helps guide prostate cancer treatment A Gleason score is a grading system used for prostate cancer. Pathologists derive the score after looking at prostate tissue samples under a microscope. Lisly Chéry, M.D., breaks down how Gleason scores are calculated how they’re used to guide prostate cancer treatment.

Many physicians use Gleason score and a corresponding Grade Group to grade prostate cancer and to determine the risk of spreading.

Dr. Lisly Chéry shares how your Gleason score can range from 6 to 10 and what those scores can potentially mean: spr.ly/63322B6mpVk #OncSky #EndCancer

Leukopenia: 6 things to know about a low white blood cell count What’s the most common reason for a low white blood cell count? Transfusion specialist Joanne Becker, M.D., answers this and five other questions about leukopenia.

Leukopenia is the scientific term for having a low white blood cell count – but its treatment depends more on symptoms than blood count numbers.

Dr. Joanne Becker explains: spr.ly/63323B6YtqJ #OncSky #EndCancer

In a moment, Leah Alvarez went from caring for brain tumor patients to facing her own brain tumor diagnosis.

Read why she chose UT MD Anderson for follow-up glioblastoma treatment: spr.ly/63326B6giLe #EndCancer

Understanding adenoid cystic carcinoma: Symptoms, treatment and outlook Adenoid cystic carcinoma is a rare cancer that is most common in the salivary glands in your head and neck. Adenoid cystic carcinoma is treatable and curable, but it often comes back. Renata Ferrarotto, M.D., shares what to know about adenoid cystic carcinoma and how her research is advancing treatment.

Because adenoid cystic carcinoma is so rare, it’s not uncommon for people to be misdiagnosed.

Our Dr. Renata Ferraroto shares what symptoms you should look for and why getting a correct diagnosis is important: spr.ly/63321B6eF9L #OncSky #EndCancer

Vitamin B12 deficiency: What to know A dietitian shares how to tell if you’re getting enough vitamin B12 and what to do if you suspect a deficiency.

While bacteria in the body make vitamin B12, our bodies can't absorb it. This means we must get vitamin B12 from outside sources.

Dietitian Grace Whitmire shares where to find B12 and how much you need in a day: spr.ly/63325B6dBT7 #OncSky #EndCancer

Rare double-hit leukemia survivor: ‘Go straight to UT MD Anderson’ Jessica Smither thought she only had one type of leukemia when she came to MD Anderson. As it turns out, she had two. Learn how a corrected diagnosis here turned her situation completely around.

"Having two different types of leukemia at the same time is so rare that the first hospital I went to didn’t even know it was possible," recalls Jessica Smither. "But the doctors at UT MD Anderson recognized it right away."

Read her story: spr.ly/63324B6bYrQ #OncSky #EndCancer

Cancerwise Podcast UT MD Anderson's Cancerwise podcast features insights from our experts on cancer diagnosis and treatment, research breakthroughs, and prevention, as well as stories from survivors and caregivers who've faced cancer firsthand.

Finding the right therapist is not one-size-fits-all.

In this Cancerwise podcast episode, learn how to recognize when it may be time to seek support and how to make sure your therapist is the right fit for you: spr.ly/6012B6wUvk #OncSky #EndCancer

Creatine powders and supplements: Should you take one? What is creatine, and is it safe for patients to take as a dietary supplement during cancer treatment? Wellness dietician Lindsey Wohlford explains.

Health claims for taking creatine range from better athletic performance and quicker recovery times to more mental clarity and even anti-aging qualities.

Wellness dietitian Lindsey Wohlford breaks down what the research actually says: spr.ly/63322B6ww4u #OncSky #EndCancer

How to reduce inflammation in the body Inflammation helps the body protect itself from injury, infection and harm. But when it sticks around long-term, it can put you at risk of health concerns. Here are nine habits that can reduce inflammation in the body.

Acute inflammation is a rapid, short-term immune response to injury or infection. But chronic inflammation is linked to serious health problems.

Learn how to reduce your risk: spr.ly/63322B6Xslw #OncSky #EndCancer

Y90-radioembolization radiation therapy for liver cancer patients Results of research from UT MD Anderson recently led to Food and Drug Administration (FDA) approval for the use of SIR-Spheres as a first-line treatment against unresectable and unablatable hepatocellular carcinoma tumors. But it took the right focus on collaboration and team science, coupled with resources, large patient volumes and unique expertise only available at UT MD Anderson for this to become a reality.

Drs. Cheenu Kappadath and Armeen Mahvash have spent much of their careers researching how to help patients with hepatocellular carcinoma live longer — and they recently unlocked a new treatment.

More about this practice-changing work: spr.ly/6016B6n3Qi #OncSky #EndCancer

A targeted therapy plus chemotherapy combination treatment was found to be safe and effective for patients with leptomeningeal metastases from breast cancer in a Phase II trial, led by UT MD Anderson researchers: bit.ly/4bh8Nsl @rkmurthy.bsky.social #EndCancer

Sigmoidoscopy: Purpose, procedure and how it compares to a colonoscopy A sigmoidoscopy is a procedure that doctors use to examine the inside of the rectum and sigmoid colon. Colon and rectal surgeon Craig Messick, M.D., shares what conditions a sigmoidoscopy helps diagnose and why it’s not a replacement for a colonoscopy.

Why would a doctor do a sigmoidoscopy? Do you need bowel prep?

Our Dr. Craig Messick answers these questions and more: spr.ly/63328B6pRor #OncSky #EndCancer

#Cancer#ChildhoodCancer
#SaveOurChildren
#HelpSaveALife
#SupportThisChild
#LittleFighter#SpreadLove
#KindnessMatters
#BeTheHope
#TogetherWeCan
#CancerAwareness
#CancerSupport
#CancerWarrior
#FightCancer
#EndCancer
#CancerJourney
#CancerSurvivor

Stage III triple-negative breast cancer survivor: Pay attention to your body April Harless was diagnosed with stage III triple-negative breast cancer despite having a clean mammogram just six months earlier. Now, she urges all her friends to practice breast awareness.

April Harless found a lump in her breast by chance.

After completing cancer treatment at UT MD Anderson, she shares what she wants others to know: spr.ly/63324B6rDtw #OncSky #EndCancer